Restricted binding of a model protein on C 3 N 4 nanosheets suggests an adequate biocompatibility of the nanomaterial
Recently, C N , a carbon nitride nanomaterial, has attracted great attention in many scientific fields due to its outstanding properties. Specifically, this nanomaterial has displayed non- or low-toxicity in biological systems suggesting its excellent biocompatibility and biosafety. Nevertheless, fe...
Gespeichert in:
Veröffentlicht in: | RSC advances 2021-02, Vol.11 (13), p.7417-7425 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recently, C
N
, a carbon nitride nanomaterial, has attracted great attention in many scientific fields due to its outstanding properties. Specifically, this nanomaterial has displayed non- or low-toxicity in biological systems suggesting its excellent biocompatibility and biosafety. Nevertheless, few studies address the structural consequences from the direct interaction between C
N
and biomolecules that could imply the physical origin of its bio-effect, particularly from the molecular level. Herein, we explored the interaction of a C
N
nanosheet and a model protein, the λ-repressor protein. We found that the C
N
nanosheet has a limited influence on the structure of the λ-repressor protein, which substantiates the outstanding biocompatibility of the nanomaterial. Detailed analyses showed that upon absorption on the C
N
nanosheet, the λ-repressor protein remains located in a relatively fixed position without compromising the structural integrity of the protein. Furthermore, the protein-nanomaterial interaction is mediated by positively charged residues located on the surface of the protein and by the regional negatively charged center on the C
N
nanosheet (
, N-rich defects). These findings provide further molecular-level insights into the good biocompatibility of the C
N
nanomaterial and also suggest its potential usage as a protein drug delivery platform. |
---|---|
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/d0ra10125g |